|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1997-3-10
|
|
pubmed:abstractText |
To investigate the value of intensive consolidation chemotherapy not followed by maintenance therapy in adult acute lymphoblastic leukemia (ALL).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:DekkerA WAW,
pubmed-author:HaakH LHL,
pubmed-author:HuijgensP CPC,
pubmed-author:LöwenbergBB,
pubmed-author:OssenkoppeleGG,
pubmed-author:SchoutenH CHC,
pubmed-author:SizooWW,
pubmed-author:SonneveldPP,
pubmed-author:VerdonckL FLF,
pubmed-author:WillemzeRR,
pubmed-author:van't VeerM BMB,
pubmed-author:van PuttenW LWL,
pubmed-author:van der LelijAA
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
476-82
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9053468-Adolescent,
pubmed-meshheading:9053468-Adult,
pubmed-meshheading:9053468-Amsacrine,
pubmed-meshheading:9053468-Antimetabolites, Antineoplastic,
pubmed-meshheading:9053468-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:9053468-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9053468-Cytarabine,
pubmed-meshheading:9053468-Disease-Free Survival,
pubmed-meshheading:9053468-Drug Administration Schedule,
pubmed-meshheading:9053468-Etoposide,
pubmed-meshheading:9053468-Female,
pubmed-meshheading:9053468-Humans,
pubmed-meshheading:9053468-Male,
pubmed-meshheading:9053468-Middle Aged,
pubmed-meshheading:9053468-Mitoxantrone,
pubmed-meshheading:9053468-Netherlands,
pubmed-meshheading:9053468-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:9053468-Remission Induction,
pubmed-meshheading:9053468-Treatment Outcome
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Dutch Hemato-Oncology Research Group.
|
|
pubmed:affiliation |
Department of Hematology, University Hospital Utrecht, the Netherlands. j.vd.velde@digd.azu.nl
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study,
Clinical Trial, Phase II
|
